| UHC Commercial Medical & Drug | Zolgensma® (Onasemnogene Abeparvovec-Xioi) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| Ambetter Health Alabama Clinical | Concert Genetic Testing: Hematology (V2.2025) | 2025-12-01 |
| Ambetter Health Alabama Clinical | Concert Genetic Testing: Otolaryngology (V2.2025) | 2025-12-01 |
| Ambetter Health Georgia Clinical | Concert Genetic Testing: Hematology | 2025-12-01 |
| Ambetter Health Georgia Clinical | Concert Genetic Testing: Otolaryngology | 2025-12-01 |
| Ambetter Health Michigan Meridian Clinical | Concert Genetic Testing: Hematology | 2025-12-01 |
| Ambetter Health Michigan Meridian Clinical | Concert Genetic Testing: Otolaryngology | 2025-12-01 |
| Meridian Illinois Medicaid Clinical | Avatrombopag (Doptelet, Doptelet Sprinkle) | 2025-12-01 |
| Meridian Illinois Medicaid Clinical | Donidalorsen (Dawnzera) | 2025-12-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Biologic and Non-biologic DMARDs | 2025-12-01 |